: PROFI : A Prospective, Randomized Trial of Proximal Balloon Occlusion vs. Filter Embolic Protection in Patients Undergoing Carotid Stenting Klaudija.

Slides:



Advertisements
Similar presentations
ACST-2 Ophthalmic sub-study Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Chairman, Dept. of Vascular Surgery,
Advertisements

Perspective randomized study on eversion carotid endarterectomy : DeBakey-Van Maele technique vs Etheredge technique. Preliminary results DOMENICO PALOMBO.
DEFINITIVE AR - Acute Outcomes -
Is Carotid Stenting an Option for Treatment of Carotid Stenosis? Joint Hospital Surgical Grand Round WH WONG Queen Mary Hospital.
Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
Can we prevent stent restenosis after coronary stent implantation
FFR vs Angiography for Multivessel Evaluation
Stenting and Angioplasty with Protection in Patients at High-Risk for Endarterectomy Presented by Jay Yadav, MD on behalf of the SAPPHIRE Investigators.
Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006 Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006.
Carotid artery stenting in the patients with high surgical risk : a single-center experience with 326 patients Jiang Xiong-jing, Teng Si-yong, Ji wei,
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs. Everolimus-Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions Julinda Mehilli,
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs. Everolimus-Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions Julinda Mehilli,
Endovascular Management of Intracranial and Extracranial Atherosclerosis Rishi Gupta, MD Associate Professor of Neurology, Neurosurgery, and Radiology.
Hind Alnajashi. C AROTID ARTERY ANATOMY Common carotid artery Aortic arch Internal carotid MCA ACA Ophthalmic artery. Cervical segment Petrous segment.
FAST (Femoral Artery Stenting Trial) Final Results Hans Krankenberg (on behalf of the FAST Investigators) Hamburg University Cardiovascular Center Prof.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Rashad MAHMUDOV Central Hospital of Oilworkers, Baku-Azerbaijan
VBWG CHARISMA Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance trial.
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
Proximal Protection during Saphenous Vein Graft Intervention using the Proxis™ Embolic Protection System The PROXIMAL Trial Laura Mauri, MD, MSc, FACC,
Epidemiology in HK  Stroke is major cause of morbidity and mortality around the world  4th cause of mortality in HK resulting in >3000 deaths every.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Patch, Bypass or Stent for Restenosis following Carotid Endarterectomy Th. Hölzenbein 1, M. Aspalter 1, K. Linni 1, N. Mader 1, W. Hitzl 2, A. Ugurluoglu.
Vascular D&C M. Uchiyama02/01/2013. Introduction  Complication  R MCA distribution embolic stroke  Procedure  R carotid angiography with planned,
ProximAl pRotection with the MO.MA device dUring caRotid stenting proximAl pRotection with the MO.MA device dUring caRotid stenting Barry T. Katzen MD.
UPDATE IN CAROTID ARTERY STENTING & STROKE MANAGEMENT Dr. Nikolaos Melas, PhD Vascular and Endovascular Surgeon Military Doctor Associate in 1st department.
Comparison of two cardiovascular risk assessment tools to determine appropriate use of aspirin as primary prevention for patients with type 2 diabetes.
SIROLIMUS-ELUTING STENTS EFFECTIVELY INHIBIT NEOINTIMAL PROLIFERATION AS COMPARED TO BARE METAL STENTS IN DISEASED SAPHENOUS VEIN GRAFTS: 6-month IVUS.
CHU C A E N EVA-3S Inferences and future directions Jacques Theron, MD Martial Hamon, MD.
Academic Medical Center Amsterdam Interventional Cardiology Koch TCT 2008 A Prospective Randomized Trial of Proximal Microcirculatory Protection in Patients.
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring Stents for De Novo.
Endovascular Treatment of Atherosclerotic Popliteal Artery Lesions – Balloon Angioplasty versus primary Stenting: A prospective, multi-centre, randomised.
Disclosure Statement of Financial Interest
Prospective, Randomized Trial of Paclitaxel-Eluting Balloon versus Paclitaxel-Eluting Stent versus Balloon Angioplasty for Treatment of Coronary Restenosis.
New embolic cerebral lesions detected with diffusion-weighted imaging after carotid artery and intracranial stent placement YH Chen, CJ Chen, DC Chen,
Departments of Neurosurgery 1, Cardiology 2, Radiology 3, Gifu University Graduate School of Medicine, Gifu, Japan. Kiyofumi Yamada 1, Shinichi Yoshimura.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Baseline Characteristics of the Patients* - Part I The ONTARGET Investigators. N Engl J Med 2008 [Epub on Mar 31]
Carotid Disease – Stent vs Surgery vs Medical Therapy? Mehdi H. Shishehbor, DO, MPH, PhD Director, Endovascular Services Interventional Cardiology & Vascular.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
CAROTID ARTERY ENDARTHERECTOMY &INTERVENTION
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset Steffen Desch, MD Thomas Stiermaier, MD; Suzanne.
A Prospective, Randomized Trial of a Paclitaxel coated Balloon vs. uncoated Balloon Angioplasty in Patients with Drug- Eluting Stent Restenosis PEPCAD-DES.
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
Statins The AURORA Trial Reference Fellstrom BC. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360. A.
Stents implantation to treat carotid lesions Lessons learned in the last 17 years Hugo Londero MD Córdoba-Argentina.
Durable Polymer DES: 5 Year Outcomes RESOLUTE Update Sigmund Silber, MD FESC, FACC, FAHA Heart Center at the Isar Munich, Germany On Behalf of the RESOLUTE.
Dr. Quan, Dr. Mirhashemi, Dr. Chiang
(p for noninferiority = 0.01)
TriGuard Device for Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: A Multicenter Real-World Experience Masieh Abawi, Ermela.
Nico H.J. Pijls, William F. Fearon, Peter Jüni, and Bernard De Bruyne
Claret Cerebral Protection Device: Implications of the Sentinel Study
CQC Amit Gossain.
Carotid Artery Stenting Predictors of procedural and clinical success
CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.
L. Nelson Hopkins, MD DISCLOSURES Consulting Fees
Vladimir Ganyukov, MD, PhD
Risk of Stroke or Death Is Associated With the Timing of Carotid Artery Stenting for Symptomatic Carotid Stenosis: A Secondary Data Analysis of the German.
Late Follow-Up from the PARTNER Aortic Valve-in-Valve Registry
Setareh Omran, MD Vascular Neurology Fellow
TUXEDO–India Trial design: Patients with type 2 diabetes mellitus (DM2) and coronary artery disease undergoing PCI were randomized to receive Taxus Element.
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO.
Inclusion Criteria for Patients with Multiple Atherothrombotic Risk Factors and for Those with Established Cardiovascular Disease Deepak L.Bhatt, et al,
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs
Transcarotid Artery Revascularization versus Transfemoral Carotid Artery Stenting for Treatment of Carotid Artery Stenosis Patric Liang, MD; Marc L.
Presentation transcript:

: PROFI : A Prospective, Randomized Trial of Proximal Balloon Occlusion vs. Filter Embolic Protection in Patients Undergoing Carotid Stenting Klaudija Bijuklic Fadija Hazizi, Andreas Wandler, Joachim Schofer Medical Care Center Prof. Mathey, Prof. Schofer Hamburg University Cardiovascular Center Germany TCT 2011

Disclosure Statement of Financial Interest I, Klaudija Bijuklic, DO NOT have a financial interest/arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.

Background Randomized trials revealed a higher periprocedural stroke rate after filter protected Carotid Artery Stenting (CAS) compared to carotid endarterectomy. Brott TG et al. N Engl J Med 2010;363:11-23 Mas JL et al. Stroke 2004;35:18-20

Background Potential disadvantages of filters Filter Have to cross the lesion before protection is installed Allow small particles to pass through or along the filter

Background Potential advantages of proximal balloon occlusion Is placed before crossing the lesion Induces reversed flow by occluding external and common carotid artery Debris is aspirated before balloon deflation Proximal balloon occlusion may be more effective than filters in preventing cerebral embolization

Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) A sensitive tool to identify new cerebral ischemic lesions after CAS Before After CAS

Study Design Design DESIGN: Prospective, randomized, dual- arm, single-center clinical evaluation of filter versus proximal balloon protected Carotid Artery Stenting (CAS) OBJECTIVE: To compare the incidence (Primary Endpoint), number, and volume (Secondary Endpoint) of new cerebral ischemic lesions assessed by DW-MRI after CAS PRINCIPAL INVESTIGATOR Joachim Schofer, MD PhD Medical Care Center Prof. Mathey Prof. Schofer, Hamburg University Cardiovascular Center, Germany 62 Patients randomized Proximal balloon n=31 Crossover to filter (n=1) 30 d Follow-up (Clinical and Duplex Ultrasound) DW-MRI Filter n=31 Crossover to proximal balloon (n=1) CAS DW-MRI h after CAS

Major Inclusion Criteria Symptomatic internal carotid artery (ICA) stenosis ≥ 60% Asymptomatic ICA stenosis ≥ 80% Lesion passage with the filter possible without predilatation Sufficient landing zone (> 4 cm) for the filter Contralateral ICA occlusion Ipsilateral ECA occlusion Major Exclusion Criteria

Baseline Characteristics Patients characteristics Filter Balloonp-value Mean age (years±SD) 71.7± ±6.6n.s. ≥ 80 years (%) 26 13n.s. Male (%) 77.4 n.s. Symptomatic (%) n.s. Diabetes (%) n.s. Smoking (%) n.s. Hypertension (%) n.s. Dyslipidemia (%) n.s. Coronary artery disease (%) n.s. Procedural variables Mean duration of procedure (min±SD) 22 ± 730 ± Mean time of protection (min±SD) 5.26± ±1.9n.s.

Incidence of new Cerebral Ischemic Lesions (Primary Endpoint) (27/31) (14/31) Filter Balloon

Filter Incidence of new Cerebral Ischemic Lesions Subgroups 12

(Secondary Endpoint) Filter Balloon Mean Number of new Cerebral Ischemic Lesions

FilterBalloon Mean Volume of new Cerebral Ischemic Lesions (Secondary Endpoint)

MACCE at 30 Days FilterBalloonp-value Death00 Major Stroke00 Minor Stroke1 (3.2%)0n.s. Myocardial infarction 00 (Secondary Endpoint)

Conclusions Whether this translates into a reduced periprocedural stroke rate has to be shown in a larger randomized trial with clinical endpoints. In this single center randomized trial in patients undergoing carotid artery stenting the incidence, number, and volume of new cerebral ischemic lesions were significantly lower under proximal balloon protection than under filter protection.

Study Design Design DESIGN: Prospective, randomized, dual-arm, single-center clinical evaluation of filter versus proximal balloon protected CAS OBJECTIVE: To compare the incidence (PE), number, and volume of new ischemic lesions assessed by DW-MRI after CAS PRINCIPAL INVESTIGATOR Joachim Schofer, MD PhD Medical Care Center Prof. Mathey Prof. Schofer, Hamburg University Cardiovascular Center, Germany 84 patients screened Between May 2010 and August patients did not meet inclusion criteria 62 patients randomized Proximal balloon n=31 Crossover to filter (n=1) Clinical and duplex ultrasound follow-up at 30 d Before and h after CAS DW-MRI evaluted by 2 blinded radiologists Filter n=31 Crossover to proximal balloon (n=1)

Ipsi- and Contralateral Lesion Incidence Ipsi- and contralateral Ipsilateral Contralateral

Reasons not to randomize Exclusion criteria for proximal balloon occlusion - Contralateral occlusion of ICA (n=7) - Ipsilateral occlusion of ECA (n=4) - Incomplete Circle of Willis (n=3) - Stenoses of both ICA and both VA (n=1) Exclusion criteria for filter protection - None of the patients (n=0) Other exclusion criteria - Pacemaker (n=2) - Claustrophobia (n=3) - In-stent restenosis (n=1) - Contralateral major stroke (n=1)

Number of Ipsi- vs Contralateral Lesions

Volume of Ipsi-vs Contralateral Lesions